Background information on the Novozymes share
Novozymes A/S’ B shares are listed on the Copenhagen Stock Exchange and are traded under ticker code NZYM B and ISIN DK0010272129. They have a nominal value of DKK 10 each.
| Share capital and voting rights |
|
|
Share capital (DKK) |
Votes |
Votes (%) |
|
| A shares |
107,487,200 |
1,074,872,000 |
66.5 |
| B shares |
542,512,800 |
542,512,800 |
33.5 |
|
| Total |
650,000,000 |
1,617,384,800 |
100.0 |
The A share capital is held by Novo A/S, which is wholly owned by the Novo Nordisk Foundation. In addition, Novo A/S holds 5,826,280 B shares, which overall gives Novo A/S 25.5% of the total share capital and 70.1% of the votes. This is why Novozymes is included in the consolidated financial statements of the Novo Nordisk Foundation. Novo A/S is domiciled in Gladsaxe, Denmark.
Novozymes’ holding of treasury shares has been included when calculating the numbers and percentages of votes held.
| Breakdown of shareholders |
| Name |
% of |
% of |
|
B share |
total share |
|
capital |
capital |
|
| Novo A/S, Gladsaxe, Denmark |
10.7 |
25.5 |
| Novozymes A/S, Gladsaxe, Denmark |
5.9 |
4.9 |
| Danish ATP, Hillerød, Denmark |
6.8 |
5.7 |
| Institutional investors, etc. |
60.4 |
50.4 |
| Private investors |
16.2 |
13.5 |
|
| Total |
100 |
100 |
The figures for institutional investors include two foreign funds each holding just below 5% of the total share capital. It is estimated that the number of private shareholders is around 65,000, of whom 44,000 are registered by name.
| Geographical distribution of shareholders |
| Country/region |
% of |
% of |
|
B share |
total share |
|
capital |
capital |
|
| Denmark |
57 |
64 |
| Rest of Europe |
22 |
18 |
| North America |
19 |
16 |
| Rest of the world |
2 |
2 |
|
| Total |
100 |
100 |
